26-Sep-2024

Maryland Affirms Admissibility

Back in October 2021, the MD v. Harvin trial court ruled that Cybergeneticsʼ TrueAllele technology met the Daubert reliability standard. The computer was deemed testable, published, and generally accepted. In September of 2024, the Maryland Appellate Court affirmed the lower courtʼs admissibility decision, establishing a state-wide precedent.

Maryland is the seventh state to affirm TrueAllele at the appellate level, joining Florida, Georgia, Nebraska, New York, Pennsylvania, and Tennessee.